Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Xalnesiran met of zonder immuunmodulator bij chronische hepatitis B
apr 2025 | Hepatitis, Virale infecties